ATLASense Biomed

ATLASense Biomed Overview

ATLASense is addressing healthcare’s most significant and growing challenge: transitioning care from hospitals to homes safely and cost-effectively while preventing life-threatening events. Introducing REPHAEL: the world’s first wearable platform delivering ICU-level monitoring and predictive insights anywhere—hospital, home, or on the go. REPHAEL isn’t just a monitor; it PREDICTS, detects, and alerts healthcare teams to critical risks like respiratory failure, sepsis, heart failure, and falls—days before they escalate. By enabling SAFE, informed clinical decisions remotely ensure hospital-level care at home. REPHAEL allows ICU-Grade Precision: Continuous, comprehensive monitoring powered by proprietary sensors and AI-driven insights. Its economical advantage: A reusable device that serves multiple patients with various morbidities, offering the lowest cost of use compared to any alternative. Enabling SAFE Decisions: Provides doctors with actionable, predictive data.

Cumulative Funding Raised Over Time ($)

Latest News

Feb 7, 2025 · news.marketersmedia.com

growth-positive

ATLASense Biomed Revolutionizes Remote Health Monitoring with REPHAEL Platform

ATLASense Biomed is showcasing its advanced remote monitoring solution, the REPHAEL platform, at the Medica Trade Fair. This platform offers ICU-grade monitoring capabilities beyond hospital settings, using a wearable device and cloud-based analytics for real-time health management. The AI-powered system provides continuous monitoring and early detection of critical conditions such as cardiac distress and sepsis. With Medicare reimbursement and FDA submission underway, the REPHAEL platform is positioned as a cost-effective, transformative solution in healthcare. ATLASense aims to enhance patient outcomes and reduce healthcare costs by making high-quality monitoring accessible in various settings.

Product Stage

Feb 7, 2025 · news.marketersmedia.com

growth-positive

ATLASense Biomed Unveils REPHAEL Platform: A New Era in Remote Health Monitoring

ATLASense Biomed is revolutionizing remote health surveillance with its REPHAEL Platform, an AI-powered system that provides early warning alerts for critical conditions like ARDS and sepsis. The platform is designed to enhance patient care in both hospital and home settings by offering predictive insights that help prevent patient deterioration. Recognized for its innovation, ATLASense has received accolades for the REPHAEL Platforms effectiveness. The company is expanding the platforms capabilities to address a broader range of health issues, aiming to improve patient outcomes and reduce healthcare costs globally.

Mar 9, 2020 · jlm-biocity.org

growth-positive

ATLASense Biomed Earns Henry Ford Health System's Global Health Tech Challenge Top Prize - JLM-BioCity

ATLASense Biomed, an Israeli-based start-up company, has won the 2020 Henry Ford Health Systems Global Health Tech Challenge for their patient monitoring system that uses predictive analytics. The company will receive up to $75,000 to further develop their technology at Henry Ford. The monitoring system has the potential to improve efficiency in hospitals and patient care. The challenge aims to identify advanced healthcare technology from Israel and launch them in the US healthcare market. ATLASense Biomeds technology uses a patch sensor placed on the patients chest to monitor physiological changes and alert staff in real-time when intervention is needed. The company believes their system has the potential to become a new standard of care in the United States.

Partners

Feb 25, 2020 · www.henryford.com

growth-positive

Patient Monitoring System Earns Top Prize in Henry Ford's Global Health Tech Challenge

Israeli start-up ATLASense Biomed has won Henry Ford Health Systems Global Health Tech Challenge for its patient monitoring system. The company will receive up to $75,000 to further research and develop its technology at Henry Ford. The monitoring system uses predictive analytics to flag real-time physiological changes in the body before, during, and after surgery. It has the potential to improve efficiency at hospitals and patient care. The technology uses a patch sensor placed on the patients chest to monitor various physiological changes, and with predictive analysis, it can alert staff when immediate intervention is needed. The goal is to develop real-time physiological monitors that can communicate directly with the electronic medical record.

PartnersInvestment

Funding

Team Members

9

Employees: 11-50

Web & Social Links

Locations

Ezer Weizman Street 1, Hod Hasharon, Israel

734 Clarence Avenue, Oak Park, IL, USA

Photos & Videos

12 item(s)

ATLASense Biomed Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info